Home

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Antibodies

Chemical Structure Cat. No. Product Name CAS No.
Avelumab Chemical Structure
BCP25212 Avelumab 1537032-82-8
Avelumab is a fully human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated cytotoxicity.
Durvalumab Chemical Structure
BCP25841 Durvalumab 1428935-60-7
Durvalumab is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody that blocks the interaction of programmed cell death ligand 1 (PD-L1) with the PD-1 and CD80 (B7.1) molecules.
Pembrolizumab Chemical Structure
BCP24244 Pembrolizumab 1374853-91-4
Pembrolizumab (formerly MK-3475 and lambrolizumab) is a humanized antibody used in cancer immunotherapy. It is an IgG4 isotype antibody that blocks a protective mechanism of cancer cells, and allows the immune system to destroy those cancer cells. It targets the programmed cell death 1 (PD-1) receptor of lymphocytes.
Ramucirumab Chemical Structure
BCP29228 Ramucirumab 947687-13-0
Ramucirumab (LY3009806, IMC-1121B, trade name Cyramza) is a fully human monoclonal antibody (IgG1) developed for the treatment of solid tumors.It is directed against the vascular endothelial growth factor receptor 2 (VEGFR2).
Eculizumab Chemical Structure
BCP26255 Eculizumab 219685-50-4
Eculizumab is a humanized monoclonal antibody functioning as a terminal complement inhibitor.
Eylea Chemical Structure
BCP29058 Eylea 845771-78-0
Aflibercept is an inhibitor of vascular endothelial growth factor (VEGF).
Rituximab Chemical Structure
BCP20918 Rituximab 174722-31-7
Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells.
Avastin Chemical Structure
BCP07998 Avastin 216974-75-3
Denosumab Chemical Structure
BCP05825 Denosumab 615258-40-7
Denosumab is a human monoclonal antibody for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone.
Trastuzumab Chemical Structure
BCP05130 Trastuzumab 180288-69-1
Trastuzumab is a monoclonal antibody used to treat breast cancer.
123下一页共 30 条记录 1 / 3 页